Wave Life Sciences (WVE) Change in Receivables (2014 - 2026)

Wave Life Sciences' Change in Receivables history runs 9 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• Quarterly Change in Receivables rose 10.27% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Dec 2025 was -$146000.0 (up 99.26% YoY) and the FY2025 annual result came in at -$146000.0, up 99.26% from the prior year.
• Change in Receivables was -$1.3 million for Q1 2026 at Wave Life Sciences, up from -$8.7 million in the prior quarter.
• Across five years, Change in Receivables topped out at $14.1 million in Q4 2023 and bottomed at -$21.1 million in Q1 2024.
• A 4-year average of $0.0 and a median of $1.3 million in 2024 frame the typical range for Change in Receivables.
• Peak annual rise in Change in Receivables reached 749.84% in 2025, while the deepest fall reached 713.5% in 2025.
• Wave Life Sciences' Change in Receivables stood at $14.1 million in 2023, then plunged by 89.9% to $1.4 million in 2024, then plunged by 713.5% to -$8.7 million in 2025, then surged by 85.37% to -$1.3 million in 2026.
• Business Quant data shows WVE's Change in Receivables at -$1.3 million in Q1 2026, -$8.7 million in Q4 2025, and $8.4 million in Q3 2025.